Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Massachusetts Weekly.
Press releases published on April 4, 2025
Xraised Interviews Jason Duffy: A Game-Changing Conversation on the Future of Industry Talent
EIN Presswire
·
April 4, 2025
CHELMSFORD, MA, UNITED STATES, April 4, 2025 /EINPresswire.com/ -- Xraised, the premier platform for industry insights and innovations, recently sat down with Jason Duffy, a key leader at Collision Action Group (CAG), to discuss the revolutionary strides …
airSlate SignNow and NavLabs Launch Seamless E-Signature Integration for Appian
EIN Presswire
·
April 4, 2025
New Partnership Brings Cost-Effective, Enterprise-Grade eSignature Capabilities to Appian’s Low-Code Platform BOSTON, MA, UNITED STATES, April 4, 2025 /EINPresswire.com/ -- airSlate, a global leader in workflow automation solutions, has announced a …
VARStreet Inc. Now Allows VARs to Create Multiple Sales Orders (SOs) from a Single Quote in VARStreet Back-office Module
EIN Presswire
·
April 4, 2025
VARStreet Inc. adds capability to generate multiple sales orders from one quote, streamlining order management. BURLINGTON, MA, UNITED STATES, April 4, 2025 /EINPresswire.com/ -- VARStreet Inc., a leading provider of quoting and eCommerce software for …
Council of Autism Service Providers Releases New Paper with Evidence About ABA Treatment for Young Children with Autism
EIN Presswire
·
April 4, 2025
Paper Establishes Connection Between Treatment Intensity and Outcomes BOSTON, MA, UNITED STATES, April 4, 2025 /EINPresswire.com/ -- The Council of Autism Service Providers (CASP) has released a new paper demonstrating the connection between applied …
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 4, 2025
WALTHAM, Mass., April 04, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced that, …
Mersana Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 4, 2025
CAMBRIDGE, Mass., April 04, 2025 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of high …
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 4, 2025
BOSTON, April 04, 2025 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage company developing a new class of genetic medicines for cardiovascular disease, today announced that on March 31, 2025, the company granted equity awards to three new employees …
Bioprocess Optimization and Digital Bio-manufacturing Market Forecast 2029
GlobeNewswire
·
April 4, 2025
Boston, April 04, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, “Bioprocess Optimization and Digital Bio-manufacturing: Global Markets” is expected to grow from $24.3 billion in 2024 to $39.6 billion by the end of 2029 at a …
After Kharkiv Close Call, American Aid Workers Promise Return to Help Ukrainian Children
EIN Presswire
·
April 4, 2025
The close call marked a dramatic moment for the 12th humanitarian convoy led by the New Hampshire-based nonprofit Common Man for Ukraine. BOSTON, MA, UNITED STATES, April 4, 2025 /EINPresswire.com/ -- Roughly 10 minutes after a group of American aid …
Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 4, 2025
FRAMINGHAM, Mass., April 04, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that in connection with the hiring of one senior leader, the Human Capital Management and …